Bañuelos Marco Beatiz, González Ricardo, Ludwikowski Barbara, Lingnau Anja
Department of Urology, Charité Medical University of Berlin, Berlin, Germany.
Pediatric Surgery and Urology, Kinder- und Jugendkrankenhaus AUF DER BULT, Hanover, Germany.
Front Pediatr. 2019 Apr 2;7:118. doi: 10.3389/fped.2019.00118. eCollection 2019.
We reviewed the literature addressing outcomes of fetal intervention of conditions that require post-natal urological management including lower urinary tract obstruction, hydrometrocolpos, congenital adrenal hyperplasia, and myelomeningocele. Despite several decades of fetal intervention for these conditions, benefits remain elusive in part because of the enormous difficulty of conducting prospective randomized studies. In this review, we reached the following conclusions: Prenatal intervention in lower urinary tract obstruction (LUTO) improves survival in the worst cases by improving pulmonary function and it may be advantageous for renal function, particularly in patients with adverse urine parameters.Prenatal treatment of female fetuses at risk of having congenital adrenal hyperplasia (CAH) reduces virilization. Non-invasive fetal DNA analysis allows earlier diagnosis, reducing the risk of treating with dexamethasone males and non-affected fetuses.Fetal treatment of myelomeningocele (MMC) is gaining momentum. Prospective studies including standardized urologic evaluation will determine if the encouraging results reported by some hold on the long term follow-up.
我们回顾了关于胎儿干预结果的文献,这些干预针对的是需要产后泌尿外科管理的病症,包括下尿路梗阻、阴道积血积脓、先天性肾上腺增生以及脊髓脊膜膨出。尽管针对这些病症进行胎儿干预已有数十年,但益处仍不明确,部分原因是开展前瞻性随机研究存在巨大困难。在本综述中,我们得出以下结论:对下尿路梗阻(LUTO)进行产前干预可通过改善肺功能提高最严重病例的存活率,对肾功能可能也有益,尤其是尿液参数不佳的患者。对有先天性肾上腺增生(CAH)风险的女性胎儿进行产前治疗可减少男性化。非侵入性胎儿DNA分析可实现更早诊断,降低对男性胎儿和未受影响胎儿使用地塞米松治疗的风险。胎儿脊髓脊膜膨出(MMC)治疗正越来越受到关注。包括标准化泌尿外科评估的前瞻性研究将确定一些研究报告的令人鼓舞的结果在长期随访中是否依然成立。